Involved field(IF) vs. extended field (EF) radiotherapy (RT) for patients in early unfavorable stages of Hodgkin's lymphoma (HL): 10-year update of the HD8 trial of the German Hodgkin Study Group (GHSG)

被引：0
|
作者：
Kriz, J. [1 ]
Sasse, S. [2 ]
Klimm, B. [2 ]
Goergen, H. [2 ]
Mueller, R. -P [3 ]
Diehl, V [2 ]
Borchmann, P. [2 ]
Engert, A. [2 ]
Eich, H. -T [1 ]
机构：
[1] Univ Munster, Klin Strahlentherapie, Munster, Germany
[2] Uniklin Koln, Innere Med Klin 1, Cologne, Germany
[3] Uniklin Koln, Klin Strahlentherapie, Cologne, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2012年 / 188卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [31] Quality Control of Involved Field (IF)-radiotherapy for Patients with Early-stage Hodgkin Lymphoma Based on a Central Prospective Review: Comparison of the Results between Two Study Generations of the German Hodgkin Study Group (GHSG)
    Kriz, J.
    Mueller, R. P.
    Bangard, C.
    Bongartz, R.
    Engert, A.
    Eich, H. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S543 - S544
  • [32] Quality Assurance of Involved Field Radiation Therapy Within the HD13 and HD14 Trial (early stages) of the German Hodgkin Study Group
    Kriz, J.
    Pluetschow, A.
    Engenhart-Cabillic, R.
    Herfarth, K. K.
    Lukas, P.
    Schmidberger, H.
    Staar, S.
    Haverkamp, U.
    Baues, C.
    Engert, A.
    Eich, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E449 - E449
  • [33] HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin's lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG).
    Diehl, V
    Brillant, C
    Engert, A
    Mueller, RP
    Mueller-Hermelink, HK
    Hermann, R
    Doerken, B
    Kanz, L
    Greil, R
    Pfistner, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 561S - 561S
  • [34] LONG-TERM FOLLOW-UP OF CONTEMPORARY TREATMENT IN EARLY-STAGE HODGKIN LYMPHOMA (HL): UPDATED ANALYSES OF THE GERMAN HODGKIN STUDY GROUP HD7, HD8, HD10 AND HD11 TRIALS
    Broeckelmann, P. J.
    Goergen, H.
    Pluetschow, A.
    Kreissl, S.
    Buerkle, C.
    Borchmann, S.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    HAEMATOLOGICA, 2016, 101 : 4 - 4
  • [35] Comparison Between the German Hodgkin Study Group (GHSG) Involved Field Radiation Therapy (IF-RI) Versus the International Lymphoma Radiation Oncology Group (ILROG) Involved Site Radiation Therapy (IS-RT) for Patients with Hodgkin Lymphoma- Is ISRT the New Standard?
    Kriz, J.
    Haverkamp, U.
    Frick, S.
    Eich, H. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S153 - S153
  • [36] Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma:: Final results of the GHSG HD7 trial
    Engert, Andreas
    Franklin, Jeremy
    Eich, Hans Theodor
    Brillant, Corinne
    Sehlen, Susanne
    Cartoni, Claudio
    Herrmann, Richard
    Pfreundschuh, Michael
    Sieber, Markus
    Tesch, Hans
    Franke, Astrid
    Koch, Peter
    de Wit, Maike
    Paulus, Ursula
    Hasenclever, Dirk
    Loeffler, Markus
    Mueller, Rolf-Peter
    Mueller-Hermelink, Hans Konrad
    Duehmke, Eckhart
    Diehl, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3495 - 3502
  • [37] Involved field (IF) radiotherapy is as effective as extended field (EF) radiotherapy after 2 cycles of COPP/ABVD in patients (pts) with intermediate-stage Hodgkin's disease (HD): A randomized multicenter study.
    Engert, A
    Schiller, P
    Pfistner, B
    Herrmann, R
    Koch, P
    Bossevin, F
    Schaber, R
    Loeffler, M
    Duehmke, F
    Mueller-Hermelink, HK
    Paulus, U
    Rueffer, JU
    Sieber, M
    Wolf, J
    Diehl, V
    BLOOD, 2001, 98 (11) : 768A - 768A
  • [38] Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review Comparison of the results between two study generations of the German Hodgkin Study Group
    Kriz, J.
    Bangard, C.
    Haverkamp, U.
    Bongartz, R.
    Baues, C.
    Engert, A.
    Mueller, R-P
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (08) : 660 - 665
  • [39] Involved node and involved field volumetric modulated arc vs. fixed beam intensity modulated radiotherapy for female patients with early stage Hodgkin lymphoma: a comparative planning study
    Weber, D. C.
    Peguret, N.
    Dipasquale, G.
    Cozzi, L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 162 - 162
  • [40] Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: Final results of the German Hodgkin's Lymphoma Study Group trial HD5
    Sieber, M
    Tesch, H
    Pfistner, B
    Rueffer, U
    Lathan, B
    Brosteanu, O
    Paulus, U
    Koch, T
    Pfreundschuh, M
    Loeffler, M
    Engert, A
    Josting, A
    Wolf, J
    Hasenclever, D
    Franklin, J
    Duehmke, E
    Georgii, A
    Schalk, KP
    Kirchner, H
    Doelken, G
    Munker, R
    Koch, P
    Herrmann, R
    Greil, R
    Anselmo, AP
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 476 - 484
12345